BIT
Click for more information
3.03% 3.4¢ biotron limited

merck looking for new hepatitis c programs

  1. Bluebush
    2,306 Posts.
    lightbulb Created with Sketch. 330
    clock Created with Sketch.
    06/01/12
    11:36
    Post #: 9516749
    Merck CEO Kenneth Frazier is deploying his deal team this year with some very specific instructions to step up their game. Speaking to an investor group, the CEO made it clear that the pharma giant needs more deals to add new therapies to the pipeline. And he's particularly interested in roping some new hepatitis C programs.

    http://www.fiercebiotech.com/story/merck-ceo-frazier-future-industry-going-be-more-partnerships/2012-01-05

    bluebush
    BIT Price at posting: 13.0¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 6  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NRX Noronex joins forces with South32 to look for copper in Namibia
right-arrow Created with Sketch.
HIQ HITIQ's sensor-containing mouthguard OK'd by World Rugby specifications board
right-arrow Created with Sketch.
ABY Adore Beauty FY24 revenues up 7.4% YoY to $196M
right-arrow Created with Sketch.
1CG OneClick surpasses 150,000 registered users
right-arrow Created with Sketch.
DMP Domino's locks in biggest faller status on Thursday as it closes stores in Asia, Europe
right-arrow Created with Sketch.
FMG Andrew Forrest was seemingly possessed by the spirit of hydrogen – now he's cut 700 jobs and canned FFI
right-arrow Created with Sketch.
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
3.4¢ 		Change
0.001(3.03%) 		Mkt cap ! $30.67M
Open High Low Value Volume
3.4¢ 3.4¢ 3.3¢ $632 18.85K

Buyers (Bids)

No. Vol. Price($)
1 287617 3.3¢
 

Sellers (Offers)

Price($) Vol. No.
3.5¢ 37989 2
View Market Depth
Last trade - 13.36pm 19/07/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.